Sunday, March 9, 2025
38.1 F
New York

FBI director defends investigations of Chinese academics in front of university audience

Speaking at the University of Michigan, Wray also said Chinese Americans are “in the crosshairs of the Chinese government,” which tries to recruit them.

Speaking at one of America’s leading public universities, FBI Director Christopher Wray offered a full-throated defense Friday of the Justice Department’s efforts to investigate and prosecute academic fraud linked to China, saying that there is no “more serious, more persistent threat to our innovation, our ideas and our economic security than the Chinese Communist Party and the Chinese government.”

Wray’s stark description of what he views as a top national security threat from China was not new, but the context was notable. Speaking to students and professors at the University of Michigan, he was answering pointed questions by a Chinese American political scientist, who asked him about a series of cases under the Justice Department’s now-abandoned “China Initiative” that had collapsed in court.

Ann Chih Lin, director of the Lieberthal-Rogel Center for Chinese Studies at the University of Michigan’s Gerald R. Ford School of Public Policy, pointed to some of those legal setbacks as she asked Wray to respond to critics who accuse the FBI “of presuming that routine academic engagement with scientific colleagues in China is evidence of a crime, or of mistaking university-sponsored collaborations and grants for money that is illicitly going into scientists’ pockets.”

Wray’s response included some of his most expansive remarks to date about FBI efforts involving American universities and China. In February, the Justice Department announced that it was abandoning the so-called China Initiative, an effort to investigate and prosecute U.S.-based professors suspected of sharing research with Chinese universities linked to the government. But Wray said the FBI continues to be concerned about Chinese government “talent programs” that sometimes pay American professors through secret relationships.

“We do not base our cases on race, ethnicity or national origin, and we haven’t,” Wray said.

Wray added that “the Chinese government, the Chinese Communist Party, is engaged in what it considers an international talent war to try to leverage and steal intellectual property and sensitive research and data from countries all over the world. … And so it’s part of our responsibility to work with universities to try to help protect that information.”

It’s important to understand hidden relationships U.S.-based academics and researchers may have with Chinese universities, Wray said, especially if the academics are conducting research funded by American taxpayers.

“I think it’s appropriate for universities and the U.S. government to make sure that there’s transparency with the university and the relevant grant-making agencies to understand what kind of relationships exist between the scholar and the Chinese government,” he said, which has “a very different objective in the way it sees the world, including suppression of human rights, including theft of intellectual property, including military dominance.”

Wray added that the FBI is not impugning the patriotism of Chinese Americans and views them as allies in its work, noting that the bureau has investigated a host of cases in which Chinese government agents are alleged to have targeted Chinese Americans or Chinese citizens living in the U.S. who have run afoul of the Communist Party.

Wray, who rarely takes questions in public from journalists, was pressed by Lin to defend his statement that “the Chinese government is engaged in a whole of society effort to steal from the United States.”

“You’ve asked that the United States engage in a similar whole of society effort to combat China,” she said. “At the same time, you also stated, as you’ve just done, that this effort isn’t about the Chinese people or Chinese Americans. But of course, Chinese Americans are part of the U.S. society that you believe needs to be mobilized against China. So what advice do you have for Chinese Americans like myself, who hope to be able to bridge the differences between our two countries, but instead find themselves caught in the middle, subject to accusations of disloyalty … or to incidents even of anti-Asian hate?”

Wray answered by noting that he only used the “whole of society” phrase once, early in his tenure. He also returned to talking about Chinese government operations that have targeted Chinese Americans.

“So, us at the FBI, we don’t view that as a middle,” he said. “We view Chinese Americans here as being with us. And that’s why I highlight these cases, in particular the transnational repression cases, because to me, they in a very poignant way illustrate the degree to which Chinese Americans here are not in the middle, but in the crosshairs of the Chinese government. And we need to work with them.”

In a telephone interview after the event, Lin told NBC News she appreciated Wray’s thoughtful answers, particularly when he stressed that the FBI’s national security concerns were directed at the Chinese government, not the Chinese people or Chinese Americans.

But she said she would have liked to see Wray acknowledge the extent to which many prosecutions of Chinese academics collapsed. She added that she believes the FBI has overstated the threat of technology transfer in an academic setting in which research is usually published for all the world to see.

“If you are consistently being overturned, that should lead you to ask whether you have an incorrect understanding of the facts, or are drawing incorrect implications from the facts,” she said.

In his remarks, Wray said that the Justice Department’s losses in court are a testament to the U.S. justice system.

“I respect the decisions of juries and judges that have found against us, just as I trust others to respect the juries and judges that have found for us in those cases where it’s gone the other way,” he said. “The fact that we sometimes lose cases actually speaks volumes about the integrity and independence of our justice system. I actually think it’s a mark in our favor as a country that the government loses cases. I’d be willing to bet you that our counterparts over in China don’t lose very many cases, and it ain’t because they’re better than we are. So there is a stark illustration of the differences between the two systems.”

Hot this week

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Topics

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Latest Cancer Treatment Breakthroughs: Advancements in Pharmacological Therapies for Better Outcomes

Cancer remains one of the most pressing health challenges globally, with millions of lives affected each year. However, the landscape of cancer treatment is continuously evolving, with groundbreaking pharmacological advancements offering new hope. The latest cancer treatment options focus on precision medicine, immunotherapy, and targeted therapies that enhance patient survival and quality of life. With recent cancer treatment breakthroughs, researchers and clinicians are increasingly optimistic about improving patient outcomes and moving closer to a cure. This article explores the newest cancer treatment advancements, including innovative drug therapies, novel treatment mechanisms, and emerging trends in oncological pharmacology.

Does Exercise Lower Cholesterol? The Science Behind Physical Activity and Heart Health

Cholesterol plays a crucial role in various physiological processes, but elevated levels, particularly of low-density lipoprotein (LDL) cholesterol, are a major risk factor for cardiovascular disease. The link between physical activity and cholesterol reduction has been extensively studied, raising the question: Does exercise lower cholesterol? Research suggests that engaging in regular physical activity can contribute significantly to improving lipid profiles, reducing cardiovascular risk, and promoting overall metabolic health. The mechanisms through which exercise impacts cholesterol levels are complex, involving enhanced lipid metabolism, increased high-density lipoprotein (HDL) production, and improved arterial function. In this article, we will examine the scientific evidence on whether exercise can lower cholesterol, explore the physiological processes involved, and discuss the best exercise strategies for optimizing cholesterol levels.

Can You Reverse Coronary Heart Disease? Understanding Risks, Treatments, and Lifestyle Interventions

Coronary heart disease (CHD) remains one of the leading causes of mortality worldwide, affecting millions of individuals each year. As the primary driver of heart attacks and other cardiovascular complications, CHD has garnered significant attention from medical professionals and researchers alike. A common question many people ask is: Can you reverse coronary heart disease? This inquiry stems from a growing interest in alternative and lifestyle-based approaches to cardiovascular health. While conventional medicine offers various treatments, emerging research suggests that lifestyle interventions, medical therapies, and dietary adjustments may play a role in reversing certain aspects of CHD. Understanding the mechanisms, risks, and available interventions can help individuals make informed decisions about their heart health.

Related Articles

Popular Categories

spot_imgspot_img